Pharmaceuticals

Afluria Quadrivalent Market Forecast 2026–2030 Highlighting Expansion Across Industries

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Afluria Quadrivalent Market From 2026 To 2030?

Historical growth was fueled by the restricted efficacy of trivalent influenza vaccines, frequent multi-strain flu outbreaks, an increase in influenza-related hospital admissions, existing immunization schedules, and public health vaccination programs.

During the projected timeframe, growth is anticipated, driven by the need for vaccines offering wider strain coverage, an increase in healthcare worker vaccinations, the expansion of pediatric immunization initiatives, increased government purchasing, and innovations in vaccine delivery methods. Significant developments expected in this period encompass the growing acceptance of quadrivalent influenza vaccines, enhanced defense against various flu strains, higher vaccination rates among vulnerable populations, the proliferation of government-led immunization programs, and progress in vaccine manufacturing technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19862&type=smp

Which Key Factors Are Driving The Afluria Quadrivalent Market Growth?

The expanding occurrence of influenza is projected to stimulate the growth of the afluria quadrivalent market in the foreseeable future. Influenza, a transmissible respiratory condition caused by viruses, can manifest as mild to severe symptoms like fever, coughing, and body aches. The growing spread of influenza is influenced by factors such as the virus’s yearly mutation, prevailing seasonal conditions, and insufficient vaccination coverage among certain demographics. Afluria Quadrivalent is vital in addressing the rising incidence of influenza by offering defense against four prevalent flu strains, consequently lowering infection risk and lessening the effects of seasonal epidemics. For example, the UK Health Security Agency, a government body based in the UK, reported in November 2024 that influenza positivity rates for week 46 demonstrated an increase, with the weekly average climbing to 3.9% from 3.3% in the prior week. Individuals aged 5 to 14 exhibited the highest positivity rates, reaching a weekly average of 11.6%, an increase from 8.8% in week 45. Consequently, the increasing prevalence of influenza is expected to fuel the growth of the afluria quadrivalent market.

Which Segment Categories Are Included In The Afluria Quadrivalent Market Segment Analysis?

The afluria quadrivalent market covered in this report is segmented –

1) By Clinical Indication: Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization

2) By Route Of Administration: Injection, Nasal Spray

3) By Age Group: Adults, Geriatric, Pediatrics

4) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Channels

5) By End-User: Hospitals, Public, Private, Clinics, Other End-Users

Who Are The Active Companies Shaping The Afluria Quadrivalent Market?

Major companies operating in the afluria quadrivalent market are Seqirus Inc.

Get The Full Afluria Quadrivalent Market Report:

https://www.thebusinessresearchcompany.com/report/afluria-quadrivalent-global-market-report

Which Region Has The Greatest Market Share In The Afluria Quadrivalent Market?

North America was the largest region in the afluria quadrivalent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Afluria Quadrivalent Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/afluria-quadrivalent-global-market-report

Browse Through More Reports Similar to the Global Afluria Quadrivalent Market 2026, By The Business Research Company

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Adalimumab Infliximab And Etanercept Biosimilars Market 2026

https://www.thebusinessresearchcompany.com/report/adalimumab-infliximab-and-etanercept-biosimilars-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795